Heart HealthResearch PaperPaywall

Angina Threshold for PCI Is Far Lower Than Current Diagnostic Cutoffs

ORBITA-FIRE reveals personalized physiological angina thresholds are dramatically lower than the universal FFR/RFR values used to guide stent decisions.

Saturday, May 9, 2026 0 views
Published in Circulation
A cardiologist in a catheterization lab reviewing pressure waveforms on a monitor, with a coronary angiography image visible on a second screen behind them

Summary

A rigorous double-blind trial called ORBITA-FIRE found that the pressure ratios at which patients actually feel angina are far lower than the universal thresholds cardiologists use to decide who gets a stent. Researchers measured FFR and RFR values at the exact moment angina was triggered in stable coronary artery disease patients, at rest and during exercise. The angina thresholds were highly individual and consistently well below current clinical cutpoints. Patients with lower personal thresholds had heavier symptom burdens and gained more relief from PCI. This suggests that one-size-fits-all physiology scores may be leaving symptomatic patients undertreated, and that personalizing revascularization decisions to each patient's symptom-linked physiology could meaningfully improve outcomes.

Deep Dive Audio
0:00--:--

Detailed Summary

Stable coronary artery disease is one of the most common conditions cardiologists manage, and deciding who needs a stent is a high-stakes judgment call. For decades, the field has relied on hemodynamic pressure ratios — fractional flow reserve (FFR) and resting full-cycle ratio (RFR) — to identify vessels causing ischemia. But these thresholds were calibrated against myocardial blood flow, not against the actual onset of chest pain. ORBITA-FIRE set out to close that gap.

The multicenter, double-blind, randomized, placebo-controlled trial enrolled 65 patients with stable angina and single-vessel coronary artery disease. After imaging-guided PCI placed a stent, an in-stent balloon was incrementally inflated — blinded to both patient and operator — until angina occurred. The corresponding FFR and RFR values at symptom onset were recorded at rest and during two levels of exercise stress.

The results were striking. Median FFR at angina onset was just 0.29 at rest, rising to 0.38 during low-intensity exercise and 0.45 during high-intensity exercise. Current clinical cutpoints sit around 0.80 — meaning patients tolerated enormous hemodynamic compromise before symptoms appeared. RFR thresholds followed the same pattern, all well below conventional diagnostic values. Crucially, patients with lower personal angina thresholds had greater symptom burden at baseline and gained more relief from PCI, suggesting the threshold itself is a clinically meaningful biomarker.

The practical implication is significant: current FFR/RFR cutoffs may be far too conservative for symptom-driven revascularization decisions. A patient turned down for PCI at FFR 0.82 may have a personal angina threshold of 0.55, meaning they are genuinely ischemic during daily activity. Personalizing physiology-guided decisions to each patient's symptom-linked threshold could identify who truly benefits from intervention.

Limitations include the relatively small sample size and the fact that the balloon inflation model creates an artificial, acute stenosis rather than chronic vessel disease. The summary is based on the abstract only.

Key Findings

  • Median FFRangina at rest was 0.29 — far below the clinical diagnostic cutpoint of ~0.80.
  • Angina thresholds rose with exercise intensity but remained consistently below universal ischemia cutoffs.
  • Lower personal angina thresholds predicted higher baseline symptom burden and greater PCI benefit.
  • Both FFR and RFR angina thresholds were highly individualized across all 65 patients.
  • Findings challenge the validity of universal physiology thresholds for symptom-driven revascularization decisions.

Methodology

ORBITA-FIRE was a multicenter, double-blind, randomized, placebo-controlled study in 65 patients with stable angina and single-vessel coronary artery disease. After imaging-guided PCI, an in-stent balloon was incrementally inflated to provoke angina, with placebo-controlled verification; FFR and RFR were recorded at symptom onset. The protocol was repeated at rest and during low- and high-intensity exercise to assess threshold shifts with cardiac workload.

Study Limitations

The study enrolled only 65 patients, limiting statistical power and generalizability across diverse CAD presentations. The balloon inflation model creates an acute artificial stenosis, which may not fully replicate the hemodynamics of chronic coronary disease. The summary is based on the abstract only, as the full text was not available.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.